Shibutani

Related by string. * * Maia Shibutani . Chris Shibutani . Alex Shibutani *

Related by context. All words. (Click for frequent words.) 51 analyst Jami Rubin 51 Yoshiyasu 49 Yumoto 49 Mochida 49 Kimihiko 49 Shigeyoshi 49 Jami Rubin 49 Yoshifumi 49 Shunichiro 48 Yuichiro 48 Norihiko 48 Ryutaro 48 Laboratories Rahway NJ 48 Hiroto 48 Hiromitsu 48 Yasunaga 47 Shigetaka 47 Yukawa 47 Katsuki 47 Shunzo 47 Ronny Gal 47 Hidehiko 47 Astellas Pharma #.T 47 Hisato 46 Yoshihisa 46 Tomoyoshi 46 Mitsuya 46 Tsujino 46 Hideto 46 Naoyuki 46 analyst Glenn Reicin 46 Takeda 46 Katsutoshi 46 Yukinori 46 Carl Seiden 46 Murashima 46 Eiichiro 45 Fumiyuki 45 Ryusuke 45 Komiya 45 Masafumi 45 analyst Cory Kasimov 45 Matsuhashi 45 Ishino 45 Hiroyoshi 45 Katano 45 Kikkawa 45 Shoichiro 45 Takashi Yamamoto 45 Seishi 45 Chris Shibutani 45 Chikako 45 Yoshinori 45 Tabuchi 45 Karasawa 45 Nagaya 45 Ryoichi 45 Chugai Pharmaceutical Co 45 Fumikazu 45 Norihiro 45 Michiaki 45 Kazufumi 45 Ritsuo 45 Geoff Porges 44 analyst Geoffrey Meacham 44 Takenori 44 Yamakawa 44 Kenji Masuzoe 44 Yoshito 44 Keijiro 44 Hisamitsu 44 Yuzuru 44 Norihito 44 Tomoaki 44 Holger Blum 44 Teruyuki 44 Takehito Yamanaka 44 Naohiro 44 Tadayuki 44 Yoshiya 44 Masatsugu 44 analyst Geoffrey Porges 44 Kyorin 44 Takehiro 44 Dr. Jim Birchenough 44 analyst George Grofik 44 Shinsuke 44 Nashimoto 44 Keizo 44 Ikeguchi 44 Hirakawa 44 Yoshiharu Izumi 44 Inagaki 44 Seiichi 44 Yasuhito 44 Takahashi 44 Fumiaki 44 Akhtar Samad 44 Katsuhiko 44 Takehiko 44 analyst Hari Sambasivam 44 Hideya 44 Nagamatsu 44 Shibata 44 Haruhiko 44 analyst Robert Cihra 44 Yoshihito 44 Yoshihiko 43 Toshihisa 43 Daiwa Asset 43 Kawakatsu 43 Taisho Pharmaceutical 43 Yoshiteru 43 Masamichi 43 Masatake 43 Keishi 43 Yoshimatsu 43 Yukihiko 43 Steven Harr 43 Kyorin Pharmaceutical Co. 43 Ohtsu 43 Junsuke 43 Takamitsu 43 Hosoya 43 Hiroshi Takada 43 Takuji 43 analyst Jonathan Aschoff 43 Akihisa 43 reaffirmed Outperform rating 43 Yasuaki 43 Naoto 43 Nagashima 43 Hirotaka 43 Shiratori 43 Hiroi 43 Majima 43 Alan Hellawell 43 analyst Glenn Novarro 43 CETP inhibitor 43 Koya Tabata 43 Yoshinari 43 Sakane 43 reaffirmed Market Perform 43 Ejiri 43 Kazaka Securities 43 Kiyotaka 43 Takayuki 43 analyst Bruce Nudell 43 Zyprexa Cymbalta 43 Toyoaki 43 Takeda Pharmaceutical Co. 43 Tomohiko 43 Joel Sendek 42 Hideharu 42 drugmaker Takeda Pharmaceutical 42 Masanao 42 Takefumi 42 Phil Nalbone 42 Toshimitsu 42 Takuro 42 analyst Noriyuki Matsushima 42 Yojiro 42 Ryuichi 42 Shigehisa 42 Toshiya 42 Kazumasa 42 Yuji Fujimori 42 Toshinobu 42 Wakatsuki 42 Shigehiro 42 Tamotsu 42 Kazutoshi 42 Reicin 42 Hirokazu 42 Uchida 42 Junji 42 analyst Shebly Seyrafi 42 Hirotsugu 42 Motoyuki 42 Shigetoshi 42 Miyachi 42 Mitsuhiro 42 Yamada 42 analyst Jim Birchenough 42 Glenn Reicin 42 Teruo 42 Mitsuyuki 42 Otsuka Pharmaceuticals 42 Lipacis 42 Larry Biegelsen 42 Taizo 42 Ohkubo 42 analyst Mark Schoenebaum 42 laninamivir 42 Katsunori 42 Kenjiro 42 Nobuhiro 42 Stanicky 42 Grofik 42 Toshiki 42 Kazuaki 42 Merck 42 Michitaka 42 Ryohei 42 Taisuke 42 Eisai Co 42 Teruhiko 42 Hiromichi 42 Masatoshi 42 Shikano 42 Maruwa Securities Co. 42 Akahane 42 Motohashi 42 analyst Yaron Werber 42 Asaoka 42 Toshiaki 42 Tadanori 42 Sankyo Co. 42 Umehara 42 Nishio 42 Tomohisa 42 analyst Gbola Amusa 42 Yoichiro 42 Yuichi 42 Endo 42 Kurimoto 42 Masamitsu 41 Ikeda 41 Shigekazu 41 Tao Levy 41 Himawari Securities 41 reaffirmed Neutral 41 Moussatos 41 Kimio 41 Isomura 41 Daiichi Sankyo #.T 41 analyst Sapna Srivastava 41 Nobuaki 41 Katy Huberty 41 Toshiro 41 Seiyaku 41 Hidenori 41 Ryosuke 41 Masashi 41 Dr. Yaron Werber 41 Hiromasa 41 Betsy Van Hees 41 Noriaki 41 Keusch 41 Nobuhiko 41 Alexandra Hauber 41 Naotaka 41 Sunao 41 Suzuken 41 Sadayuki 41 Yoshiharu 41 Isogai 41 Hoshina 41 Bansei Securities 41 Satoshi 41 Takashi 41 analyst Kazuharu Miura 41 Yukihiro 41 Mamoru 41 Molowa 41 Tsumura 41 Bayer Yakuhin 41 Manabu 41 Yaron Werber 41 Taisho Pharmaceutical Co 41 Arisawa 41 Kazuyo Katsuma 41 Katsuhide 41 analyst Jim Reddoch 41 Geoff Meacham 41 Yasunori 41 Katsunobu 41 Sankyo 41 Hideshi 41 Morgan Stanley economist Takehiro 41 Setsuo 41 Masatoshi Kikuchi 41 Timothy Arcuri 41 Toyama Chemical 41 Shinichi Tamura 41 Mitsuo 41 Higuchi 41 Katsushi 41 Kazuhito 41 Hidehiro 41 Kazuyoshi 41 Hisashi 41 Kanehira 41 Taisho Pharmaceutical Co. 40 Mark Monane 40 Nobuyasu 40 Joanne Wuensch 40 Tomonari 40 Miyatake 40 Okasan 40 Owaki 40 Pariet 40 economist Joachim Fels 40 Masahiro Ono 40 Kiichi 40 Ikuo 40 Takeda Pharmaceutical #.T 40 Teruaki 40 Akifumi 40 Nishibori 40 Nobuya 40 Takehiro Sato economist 40 Shuichi 40 Takahiko 40 Inoue 40 Iwasawa 40 Akazawa 40 Bret Holley 40 Zensana 40 Nishimae 40 Tomoyo Fukuda 40 Maynard Um 40 Akihiko 40 Daeshin Securities 40 Takaaki 40 Yoshihiro 40 Sakagami 40 Promus stent 40 Sam Fazeli 40 Masayuki 40 TKPHF 40 Naofumi 40 Toshitaka 40 Shinichiro 40 Masaki 40 Shigeo 40 David Amsellem 40 analyst Hitoshi Kuriyama 40 Bill Shope 40 Ohtsuka 40 Hamano 40 Toshiyuki 40 Chillara 40 Kyorin Pharmaceutical 40 Hidetaka 40 Izumiya 40 Joe Osha 40 Kazunari 40 Yasutoshi 40 Nikko Citi 40 Eiji 40 Katsuyuki 40 Dainippon 40 analyst Alexandra Hauber 40 Yasunobu 40 Hiroyasu 40 Masanobu 40 Amitiza lubiprostone 40 Andrew Goodsall 40 Hisataka 40 Tatsuhiko 40 Fukao 40 analyst Seamus Fernandez 40 Toshifumi 40 analyst Dara Mohsenian 40 analyst Shinichi Ichikawa 40 Kevin Scotcher 40 Eisuke 40 Bayer Yakuhin Ltd. 40 Kenichiro 40 Sekine 40 Tadahiro 40 Chugai Pharmaceutical Co. 40 Shuji Shirota economist 40 Keiichi 40 Hiroyuki 40 Kota Yuzawa 40 Norimasa 40 analyst Shunsuke Tsuchiya 40 Matt Miksic 40 Yukihiko Shimada 40 Tomohiro 40 Masaru 40 Yoshinobu 40 Nichi iko 40 Shinichi 40 Forest Labs FRX 40 Motoo 40 Hiroji 40 Takatori 40 Shinya Yamada 40 Masaharu 40 Eiichi 40 Banyu 40 Tanabe Seiyaku Co. 40 Dr. Baim 40 Fumihiro 40 Koichi 40 Hirotoshi 40 Satoru 40 Banyu Pharmaceutical Co. 40 Kazutaka 40 Astellas Pharmaceuticals 40 Masataka 40 Masahide 40 Hironobu 40 Shibahara 39 Takemi 39 Theo Kitz 39 Wyeth 39 Yamanouchi 39 Yuichi Sato 39 Astellas Pharma Inc 39 Martin Possienke 39 Masayuki Otani deputy 39 Michihiro 39 Tsutomo 39 Shuichiro 39 Glenn Novarro 39 Mizutani 39 Seiichiro 39 Hidekazu 39 Leerink 39 analyst Maged Shenouda 39 Fukaya 39 George Grofik 39 Naoya 39 Fumiaki Sato 39 Japanese drugmaker Eisai 39 Katsuhito Sasajima 39 BernsteinResearch 39 Dominic Valder 39 Naoki 39 Kissei 39 Monane 39 Tetsuro 39 spokeswoman Mariann Caprino 39 Takahito 39 Kazuya 39 Ian Somaiya 39 Robert Spanheimer 39 Roopesh Patel 39 Kanayama 39 Tomonori 39 analyst Sterling Auty 39 Koya Tabata analyst 39 Ohnishi 39 Taisho 39 Hisao 39 Watanabe 39 Ryuzo 39 Osamu Hirose 39 Yasuyuki 39 Oncolys BioPharma 39 Tomoyuki 39 Stacy Rasgon 39 Ehud Gelblum 39 Tetsuji 39 Japanâ 39 Teruhisa 39 Gelblum 39 Asahi Kasei Pharma 39 Morooka 39 Kuniaki 39 SMBC Friend 39 Junichi Ujiie chairman 39 Hirofumi 39 Cory Kasimov 39 strategist Abhijit Chakrabortti 39 Toichi 39 Jason Kantor 39 Jim Birchenough 39 Iio 39 Banyu Pharmaceutical 39 Krensavage 39 Takeshi 39 Yamanouchi Pharmaceutical Co 39 analyst Yuji Fujimori 39 Masayoshi 39 Lexapro escitalopram 39 Shebly Seyrafi 39 Toshihiko 39 Andreas Theisen 39 Tomokazu 39 Yasuhiro 39 analyst Hisashi Moriyama 39 Dainippon Sumitomo Pharma 39 Shunji 39 analyst Rebecca Runkle 39 Masahiko 39 Dorothy Lakner 39 Dainippon Sumitomo 39 Masami 39 analyst Dean Gianoukos 39 Yasuhisa 39 analyst William Pecoriello 39 Yukichi 39 Kumazawa 39 Takeaki 39 Kazuhide 39 analyst Shinichi Ina 39 Lurasidone 39 Daizo 39 analyst Larry Biegelsen 39 Hisamitsu Pharmaceutical Co. 39 Hiroshi Matsuda 39 Onogi 39 Masanori 39 Daiichi Sankyo Co. 39 Akihiro 39 Shotaro Noguchi 39 Takeda Pharma 39 Takada 39 Veterinarian Manual 39 Takagi 39 Kazutaka Oshima 39 Ryoji 39 Shigeyuki 39 Katsumi 38 analyst Lawrence Keusch 38 Mitsutoshi 38 Atsushi 38 Nobuo 38 Akinobu 38 Eric Ende 38 Santen Pharmaceutical Co. 38 Mizuta 38 John DiFucci 38 Yasuhiko 38 Masakazu 38 Yamanouchi Pharmaceuticals 38 analyst Gurinder Kalra 38 analyst Joanne Wuensch 38 Masdea 38 Kadono 38 Hiroshi 38 Kusakabe 38 Ueda 38 Katsumasa 38 Denhoy 38 Annabel Samimy 38 Kirin Brewery Co. 38 Ronald W. Dollens 38 Geoffrey Porges 38 Naohiko 38 Recentin 38 Michael Bruynesteyn 38 Yoshitaka 38 Ichiyoshi 38 Kash Rangan 38 Fumitaka 38 Jason Kolbert 38 Shinyoung Securities Co. 38 Atsuo 38 Nomaguchi 38 Jonathan Allum 38 Sherri Scribner 38 analyst Uche Orji 38 Toshiharu 38 Co LLY.N 38 Kunihiko 38 Xenoport 38 JGB strategist 38 Teijin Pharma Limited 38 Noboru 38 Hiroshi Tanaka 38 Muramatsu 38 Rozerem 38 Taxus drug eluting 38 Mitsubishi Pharma 38 Sterling Auty 38 analyst Ashwin Shirvaikar 38 Fumihiko 38 Eli Kammerman 38 analyst Bill Pecoriello 38 Toru 38 analyst Tal Liani 38 Cordis stent 38 Yoshio 38 DPP4 inhibitor 38 economist Ryo Hino 38 Kohno 38 analyst Jason Brueschke 38 Japanese drugmaker Takeda 38 analyst Randall Stanicky 38 Tsugio 38 Kiyokazu 38 Daiichi Sankyo Co 38 analyst Amit Hazan 38 Kunimatsu 38 Bansei Securities Co. 38 Susumu 38 analyst Yoshiharu Izumi 38 Zocor Zetia 38 Liana Moussatos 38 analyst Ehud Gelblum 38 Toshimichi 38 Masakatsu 38 Kin Ho 38 Satya Kumar 38 Geoffrey Meacham 38 Takeda Pharmaceutical 38 Hideaki 38 Nobuki 38 Mitsubishi Tanabe Pharma 38 Kenji Kawada 38 Akinori 38 Yakuhin 38 analyst Simos Simeonidis 38 analyst Brian Modoff 38 Ken Cacciatore 37 analyst Dorothy Lakner 37 Etsuo 37 Nobuyuki 37 Shigeru 37 Naoki Yuasa 37 replaces Takeo Fukui 37 Carla Antunes da Silva 37 Konishi 37 strategist Anais Faraj 37 TAKEDA 37 Daniel Heyler 37 Shinshu University 37 Otsuki 37 Abbott Xience V 37 Joshua Schimmer 37 Hiroichi Nishi equities 37 Rikiya 37 Yabe 37 Kamiyama 37 Inadome 37 Edward Tenthoff 37 Drickamer 37 strategist Makoto Yamashita 37 Noriyuki Matsushima 37 Junichi 37 Katsuhiro 37 companies visit www.tpna.com 37 UFJ Tsubasa 37 Scott Geels 37 Toshikatsu 37 Niihara 37 analyst Eileen Furukawa 37 economist Huang Yiping 37 Shuzo 37 Sepracor SEPR 37 Naoaki 37 Resolute stent 37 Tochigi prefecture north 37 analyst Dinesh Moorjani 37 Biogen IDEC 37 Medtronic Endeavor 37 Kosuke 37 Tsukasa Noda 37 Sanwa Kagaku Kenkyusho 37 Teijin Pharma 37 Shigenori 37 B. Nemeroff 37 analyst Thilo Wrede 37 analyst Jeetil Patel 37 Dr. Joshua Schimmer 37 Takeda Chemical 37 Japanese drugmaker Daiichi 37 Otsuka 37 analyst Emme Kozloff 37 Aaron Reames 37 Fujisawa 37 Yoshinobu Yamada 37 Jesper Koll 37 Yuhei 37 Bert Hazlett 37 Dealmaking Profile 37 Takeda Pharmaceutical Co 37 analyst Rommel Dionisio 37 economist Junichi Makino 37 Fukoku Mutual 37 Nakada 37 Dokkyo University 37 Yoshihide 37 analyst Srini Pajjuri 37 AnGes MG 37 Hamed Khorsand 37 analyst Benjamin Swinburne 37 analyst Amit Bhalla 37 Bruce Nudell 37 Kabu.com Securities 37 Yamawaki 37 Toyahara 37 Taiho Pharmaceutical 37 Mosesmann 37 Glen Yeung 37 Jesse Tortora 37 Co MRK 37 Ohashi 37 Aizawa Securities 37 analyst Shotaro Noguchi 37 Hironori 37 senior economist Tatsushi 37 analyst Ittai Kidron 37 Calyon Capital Markets 37 Hitoshi 37 analyst Julio Quinteros 37 Ehsan Syed 37 Gbola Amusa 37 analyst Robert Koort 37 Yoshikazu 37 Ulrich Huwald 37 oil refiner Idemitsu 37 analyst Elizabeth Osur 37 Shunichi 37 Tadashi 37 analyst Masahiro Ono 37 Kyowa Hakko Kirin 37 IG HCR ;) CO 37 Jonathan Ruykhaver 37 Chugai Pharmaceutical 37 Sawai Pharmaceutical 37 Lawrence Biegelsen 37 analyst Inder Singh 37 Takeda Pharmaceuticals 37 Yoshitomo 37 FXOnline Japan 37 Kazumasa Yamaoka senior 37 Mark Schoenebaum 37 Meiji Seika 37 Masaaki 37 Darcy Travlos 37 Sawai Pharmaceutical Co. 37 Iwashita 37 Tatsuro 37 Promus Element 37 Onyx Pharma 37 Hiroaki 36 Teikoku Seiyaku 36 Toshihiro 36 Norikazu 36 Yozo 36 analyst Walter Piecyk 36 Rob Cihra 36 Mizobuchi 36 analyst Romit Shah 36 Kiyofumi 36 Takahiro 36 Jon LeCroy 36 Takahagi 36 Iwao 36 Taiho 36 Nancy Wysenski 36 Shigenori Okazaki political 36 analyst Vivek Arya 36 analyst Ken Trbovich 36 Katsuji 36 Minami 36 Tomoharu 36 Japan 36 Kunio 36 Shionogi 36 Abilify 36 Fujinuma 36 Fujiyoshi 36 Fanapt iloperidone 36 economist Tetsufumi Yamakawa 36 Torikoshi 36 Kazuho 36 Kaneyama Securities 36 Xience 36 Yoshitsugu 36 analyst Pablo Zuanic 36 Pfizer 36 Takanori 36 Roche ROG.VX 36 United Therapeutics UTHR 36 spokesman Tony Plohoros 36 Inavir 36 Eiji Dohke 36 analyst Nigel Dally 36 analyst Jeff Fidacaro 36 Jeffrey Holford 36 Hanao 36 Takehiro Sato 36 Daiichi Suntory Pharma 36 economist Laurent Bilke 36 Mark Lipacis 36 Chugai Pharma 36 analyst Jason Helfstein 36 analyst Allan Mishan 36 Endo Pharmaceutical 36 economist Masamichi Adachi 36 Inc. MDT.N 36 Yakult Honsha Co. 36 Biegelsen 36 Takara Bio Inc. 36 Kazuharu 36 Hamamura 36 Leerink Swan 36 Meiji Seika Kaisha Ltd. 36 analyst Yukio Takahashi 36 Kawano 36 Hideyuki Suzuki 36 economist Naoki Murakami 36 Simos Simeonidis 36 Song Kyung keun 36 analyst Takaki Nakanishi 36 Jeremy Sigee 36 Aciphex 36 John Calcagnini 36 Masahiro 36 Ohmori 36 Ogawa 36 Fumio 36 Gattex 36 analyst Tristan Gerra 36 Teikyo University 36 Taiho Pharmaceutical Co. 36 strategist Naomi Hasegawa 36 Kissei Pharmaceutical 36 Makoto 36 Curagen 36 Tatsushi 36 analyst Bruce Cranna 36 analyst Frank Mitsch 36 Eli Lilly LLY 36 Sung Jin kyung 36 Norio 36 Kenichi Yumoto 36 Japanā 36 Kissei Pharmaceutical Co. 36 analyst Katy Huberty 36 analyst Elemer Piros 36 Toshikazu 36 analyst Brad Reback 36 Furuta 36 generation Taxus Liberte 36 Jay Vleeschhouwer 36 Takeo Miyamoto 36 analyst Annabel Samimy 36 Bristol Myers Squibb BMY 36 analyst Mark Lipacis 36 Tobias Levkovich 36 Kyowa Hakko Kogyo Co. 36 Tagaya 36 Ichiyoshi Securities 36 Masaaki Kobayashi 36 Nishimura 36 Satoru Takada 36 analyst Mark Edelstone 36 Takayoshi 36 Elga Bartsch economist 36 analyst Amit Daryanani 36 Nippon Shinyaku 36 Peter Appert 36 analyst Ryosuke Katsura 36 Niimura 36 Morinaga 36 Otsuka Pharmaceutical 36 Makoto Murayama 36 SymBio 35 Interes Capital Management 35 Fujio 35 Mika Watanabe 35 kabu.com Securities 35 analyst Stephen Tusa 35 James Covello 35 Jun Kato 35 Actos pioglitazone 35 Pirespa 35 Kitasato 35 Chotaro Morita head 35 Tetsuhiro 35 analyst Jay Defibaugh 35 Rapinyl 35 Miyaji 35 Hideyuki 35 ZoMaxx 35 Douglas Harned 35 analyst Jeffrey Kvaal 35 Tero Kuittinen 35 Takuo 35 Masao 35 Pablo Zuanic 35 economist Hiromichi Shirakawa 35 Mochida Pharmaceutical Co. 35 Sumitomo Mitsui Asset 35 Yasuchika Hasegawa 35 Michael Leuchten 35 Daniel Berenbaum 35 Toshiro Yoshinaga 35 analyst Robert Campagnino 35 Hisaaki Tasaka 35 Ricky Goldwasser 35 Koichi Hariya 35 Anais Faraj strategist 35 Tantallon Research 35 analyst Victor Bareno 35 Ayabe 35 Yasuaki Iwamoto 35 Elan Pharma 35 Kyowa 35 Edwards Lifesciences EW 35 analyst Doug Leggate 35 Lawrence Keusch 35 Sumitomo Pharmaceuticals 35 Hashimoto 35 Todd Raker 35 Ryuichiro 35 Justin Hott 35 Joseph Pantginis 35 Helene Wolk 35 Santen Pharmaceutical 35 TonenGeneral 35 Jeff Kvaal 35 Kazuhiro 35 Ittai Kidron 35 Yasuo 35 Ferragu 35 William Pecoriello 35 Senju 35 Takehisa 35 Uloric 35 Durect 35 Torii Pharmaceutical 35 Schering-Plough/Merck 35 Zadaxin 35 analyst Colin McGranahan 35 Humira 35 Takafumi 35 Tatsuo Yoshida auto 35 Kazushige 35 Nobumasa 35 Oppenheimer Yair Reiner 35 Hibino 35 JoAnne Feeney 35 Eiichi Katayama 35 analyst Peter Nesvold 35 Eric Coldwell 35 Abbott Xience 35 Natixis Bleichroeder analyst 35 Nihon Pharmaceutical 35 Rohto Pharmaceutical 35 Kirk Boodry 35 Simdax 35 Bayer Healthcare 35 Ube Industries 35 analyst Kathryn Huberty 35 Dao Heng Securities 35 Schering 35 Masayasu 35 Shinichi Ichikawa 35 Fujitomi 35 Bruce Cranna 35 analyst Phillip Nalbone 35 Shinke 35 Hitoshi Asaoka 35 Meiji Seika Kaisha 35 analyst Ross Muken 35 Dhulsini de Zoysa 35 Kaneka Corporation 35 Rebecca Runkle 35 Biegelsen wrote 35 Christopher Danely 35 BernsteinResearch analyst 35 Kanetsu Asset Management 35 Shosuke 35 Mahesh Sanganeria 35 Yamanouchi Pharmaceutical Co. 35 Exanta 35 Trevor Mundel 35 Kazunori 35 NESINA 35 Okasan Securities strategist 35 Dainippon Pharmaceutical 35 TAXUS paclitaxel eluting coronary 35 analyst Frederick Searby 35 Taxus Liberte 35 Tomoko Abe 35 Analyst Andrew Zarnett 35 Nippon Kayaku 35 Daiichi Sankyo 35 Noriyoshi 35 Nishiwaki 35 analyst Mark Monane 35 Kunihiro Matsumoto 34 Mitsugu 34 Rod Bourgeois 34 Immunex Corp. 34 Daiichi Pharmaceutical 34 David Molowa 34 analyst Kota Yuzawa 34 Stefan Worrall 34 Wataru Kasatani financial 34 blood clot preventer 34 Tanabe Seiyaku 34 Hajime 34 AstraZeneca plc 34 Shinya Naruse 34 Kazuya Yamamoto 34 Paul Lejuez 34 Muraglitazar 34 Neely Tamminga

Back to home page